Skip to content

Clinical trials

Observational Essential Hypertension trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Essential Hypertension Phase: Observational Country / region: China Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20101
20131
20162
20223
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status6
Completed3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer1
Beijing Chao Yang Hospital1
Beijing Institute of Heart, Lung and Blood Vessel Diseases1
Guangdong Provincial People's Hospital1
Hasten Biopharmaceutical Co., Ltd.1
Peking University First Hospital1
The Second Affiliated Hospital of Chongqing Medical University1
Third Military Medical University1
Zhujiang Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Essential Hypertension9
Cardiovascular Diseases2
Hyperaldosteronism2
Hypertension2
Acute Coronary Syndrome1
Adrenocortical Adenoma1
Atrial Fibrillation1
Cytomegalovirus Infections1
Endocrine System Diseases1
Epilepsy1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.